Blog - Page 3055 of 5752

MondayJul 01, 2013 9:25 am

Soligenix, Inc. (SNGX) Completes Phase 1 Study with SGX203, Treatment of Pediatric Crohn’s Disease

Soligenix, a clinical stage biopharmaceutical company developing products to treat serious gastrointestinal diseases, has enrolled and treated all 24 patients in the phase 1 Study BDP-PCD-01, the first clinical study for development of SGX203 (oral BDP) for the treatment of pediatric Crohn's disease. The objective of Study BDP-PCD-01 was to further characterize the pharmacokinetic (PK) and pharmacodynamic (PD) profile of the company's proprietary oral BDP formulation. Soligenix reports that the data was complementary to results previously obtained and confirms the safety profile observed in all previous clinical studies with oral BDP. This study enrolled subjects between the ages of 18-22.…

MondayJul 01, 2013 9:14 am

Respect Your Universe, Inc. (RYUN) Announces James R. Nowodworski as CFO

Respect Your Universe announced that Mr. James R. Nowodworski has been appointed as its Chief Financial Officer, effective July 23, 2013. Mr. Nowodworski is replacing Aaron Loreth, who recently resigned as the company’s CFO. "We are lucky to have a seasoned business and financial professional of Jim's caliber join our team in a senior financial management position," noted Craig Brod, RYU’s Chief Executive Officer. "We look forward to Jim's active role in guiding the financial management of our company and our anticipated successful expansion in the retail sector. We are excited to have him on board." Mr. Nowodworski, a Certified…

MondayJul 01, 2013 8:38 am

Rainbow Coral Corp. (RBCC) Partner Successfully Raises Funds for New Drug Delivery Solutions

Today before the opening bell, Rainbow Coral applauded the fundraising results achieved by joint venture partner TheraKine, Ltd. “TheraKine has done a tremendous job of bringing in outside funds to help push its innovations further into a hungry marketplace,” said RBCC CEO Patrick Brown. “The interest in TheraKine’s new drug delivery solutions is a fantastic illustration of this new system’s incredible market potential.” Rainbow Coral signed a joint venture agreement with TheraKine earlier this year to help market and develop a revolutionary, sustained-release drug delivery platform designed to make local delivery of biologic agents and small molecules safer, more effective,…

FridayJun 28, 2013 3:43 pm

South American Gold Corp. (SAGD) Offers Operational Update and Corporate Project Overview for 2013 Activities

South American Gold has assembled a nice portfolio of gold and silver exploration interests, both at home here in the U.S. with their New Light Mine gold-silver project up in northern Washington State, the Baltimore Silver project in Montana, the newer Kelly Project group of mining claims in western Montana, and the GB-2 mining claims in Arizona, as well as abroad in Colombia via the Narino Department in the south and the Santacruz Gold project. Today the company was pleased to offer markets a sweeping update on their 2013 activities and developments. The company is hard at work vetting existing…

FridayJun 28, 2013 1:02 pm

The Guitammer Company (GTMM) – Technological Evolution in Motion

The Guitammer Company was founded by musician, composer, and producer Ken McCaw, who was looking for a way to commercialize a patented guitar accessory called the Hammer Jammer. The next product to emerge from Guitammer was the solution to a problem McCaw and his drummer were experiencing in wanting to be able to feel the low end without turning the stage monitors up so loud that it disturbed the rest of the band. This was the moment the idea for ButtKicker® brand low frequency audio transducers were born, offering monitoring, timing, and synchronization by allowing the musicians to feel the…

FridayJun 28, 2013 12:31 pm

VistaGen Therapeutics, Inc. (VSTA) Issues Update on $36M Strategic Financing Agreement with Autlion

VistaGen Therapeutics, a biotechnology company applying stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, recently delivered an overview of key developments involving its CardioSafe 3D™ and LiverSafe 3D™ bioassay systems in poster presentations at the 11th Annual Meeting of the International Society of Stem Cell Research (ISSCR), the largest forum for stem cell and regenerative medicine professionals from around the world, held last week in Boston, Massachusetts. Dr. Hai-Qing Xian, Senior Scientist, presented VistaGen’s poster entitled “Cardiotoxicity Assessment of Anti-Cancer Kinase Inhibitors using Human Pluripotent Stem Cell-Derived Cardiomyocyte Based Assays,” which detailed important developments demonstrating that…

FridayJun 28, 2013 12:16 pm

Biostem U.S. Corporation (HAIR) Spammed Aggressively

We have observed an unsolicited emails spamming Biostem. Investors should be wary of these emails, as they are completely anonymous and violate the CAN-SPAM Act established by the FTC. As of this time, the company has not provided a public comment on the issue. Stocks to avoid, due diligence, monitoring investments, key terms in investing and other related topics are covered by us in our Market Basics section. Here we give answers to basic questions regarding stock investments for both new and experienced investors. To view our Market Basics page, visit www.basics.qualitystocks.net. QualityStocks also helps protect investors by rating thousands…

FridayJun 28, 2013 11:55 am

VentriPoint Diagnostics Ltd. (VPTDF) Offers Superior Solution to Right Heart Analysis

VentriPoint Diagnostics is a Seattle-based provider of a superior heart analysis system. The VentriPoint technology uses conventional 2-dimensional ultrasound data, plus a patented system for analyzing the data called Knowledge-Based Reconstruction (KBR). The result is a 3-dimensional model of the heart, providing critical information regarding things like heart volumes and cardiac output. The VentriPoint system, called Angelo, is of special value for doing what is called right-heart analysis, where the physician needs a clear view of the portion of the heart that pumps blood to the lungs for oxygenation. It is normally difficult to image the right heart using ultrasound,…

FridayJun 28, 2013 11:43 am

TeleCommunication Systems Inc. (TSYS) Video Chart for Friday, June 28, 2013

TSYS has made a strong move over the past week to rise about 20 percent to face a resistance point at $2.40. Should the pps break the resistance, which will keep it over the 50-day and 200-day moving averages, there is not much resistance until old highs at $2.70. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

FridayJun 28, 2013 10:04 am

QualityStocks Productions Releases Rafarma Pharmaceuticals, Inc. (RAFA) Video Exposing Company’s Strategic Position

The Russian pharmaceutical sector is roaring forward, estimated to reach a value of $10.7 billion by 2014 and $60 billion by 2020, fueled by the Russian Government’s initiatives to bolster the country’s domestic pharmaceutical market. Rafarma Pharmaceuticals aims to take its fair share of the market and emerge as one of the Top 3 Russian pharmaceutical companies within the next decade. To reach this goal, Rafarma has built a new world-class 270,000 square-foot manufacturing plant in a strategic location and operated by a highly classified management team. A recent video published by QualityStocks Productions highlights Rafarma’s position in the burgeoning…

Site Search

Company Search